ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Lipid parameters, adipose tissue distribution and prognosis prediction in chronic kidney Disease patients

Chen, Hui-fen; Xiao, Bing-jie; Chen, Lin-yi; Ouyang, Wen-wei; Zhang, Xian-long; He, Zhi-ren; Fu, Li-zhe; Tang, Fang; Tang, Xiao-na; Liu, Xu-sheng*; Wu, Yi-fan*广东省人民医院; 广州中医药大学
Lipids in Health and Disease2024-1-8DOI: 10.1186/s12944-024-02004-4
6阅读
引用收藏
分享

摘要

BackgroundLipid management in clinic is critical to the prevention and treatment of Chronic kidney disease (CKD), while the manifestations of lipid indicators vary in types and have flexible association with CKD prognosis.PurposeExplore the associations between the widely used indicators of lipid metabolism and their distribution in clinic and CKD prognosis; provide a reference for lipid management and inform treatment decisions for patients with non-dialysis CKD stage 3-5.MethodsThis is a retrospective cohort study utilizing the Self-Management Program for Patients with Chronic Kidney Disease Cohort (SMP-CKD) database of 794 individuals with CKD stages 3-5. It covers demographic data, clinical diagnosis and medical history collection, laboratory results, circulating lipid profiles and lipid distribution assessments. Primary endpoint was defined as a composite outcome(the initiation of chronic dialysis or renal transplantation, sustained decline of 40% or more in estimated glomerular filtration rate (eGFR), doubled of serum creatinine (SCr) from the baseline, eGFR less than 5 mL/min/1.73m2, or all-cause mortality). Exposure variables were circulating lipid profiles and lipid distribution measurements. Association were assessed using Relative risks (RRs) (95% confidence intervals (CIs)) computed by multivariate Poisson models combined with least absolute shrinkage and selection operator (LASSO) regression according to categories of lipid manifestations. The best model was selected via akaike information criterion (AIC), area under curve (AUC), receiver operating characteristic curve (ROC) and net reclassification index (NRI). Subgroup analysis and sensitivity analysis were performed to assess the interaction effects and robustness..Results255 individuals reached the composite outcome. Median follow-up duration was 2.03 [1.06, 3.19] years. Median age was 58.8 [48.7, 67.2] years with a median eGFR of 33.7 [17.6, 47.8] ml/min/1.73 m2. Five dataset were built after multiple imputation and five category-based Possion models were constructed for each dataset. Model 5 across five datasets had the best fitness with smallest AIC and largest AUC. The pooled results of Model 5 showed that total cholesterol (TC) (RR (95%CI) (per mmol/L) :1.143[1.023,1.278], P = 0.018) and percentage of body fat (PBF) (RR (95%CI) (per percentage):0.976[0.961,0.992], P = 0.003) were significant factors of composite outcome. The results indicated that comprehensive consideration of lipid metabolism and fat distribution is more critical in the prediction of CKD prognosis..ConclusionComprehensive consideration of lipid manifestations is optimal in predicting the prognosis of individuals with non-dialysis CKD stages 3-5.

学科与关键词

关键词
Chronic kidney diseaseLipid profilesLipid distribution
相关
加载中…
  • Optimal Obesity- and Lipid-Related Indices for Predicting Metabolic Syndrome in Chronic Kidney Disease Patients with and without Type 2 Diabetes Mellitus in China
    Li, Hangtian; Wang, Qian; Ke, Jianghua; Lin, Wenwen; Luo, Yayong; Yao, Jin; Zhang, Weiguang; Zhang, Li; Duan, Shuwei; Dong, Zheyi*; Chen, Xiangmei*OncoImmunology, 2022, 14(7): 1334.被引 5
  • The Association between Baseline Serum Lipids and Mortality in Peritoneal Dialysis Patients
    Xie, Qionghong; Shang, Da; Wang, Yujia; Zhang, Min; Chen, Yun; Xu, Rong; Han, Qingfeng; Ren, Yeping; Chen, Jianghua; Zhao, Huiping; Chen, Menghua; Dong, Jie; Hao, Chuan-Ming; Zhu, Tongying*Blood Purification, 2022, 51(2): 101-110.被引 2
  • Developing and validating a prognostic prediction model for patients with chronic kidney disease stages 3-5 based on disease conditions and intervention methods: a retrospective cohort study in China
    Zhang, Min; Lei, Nuo; Zhang, Xian-Long; Xu, Yanmin; Chen, Hui-Fen; Fu, Li-Zhe; Tang, Fang; Liu, Xusheng; Wu, Yifan*BMJ Open, 2022, 12(5): e054989.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Lipids in Health and Disease
发表日期
2024-01-08
卷期
第 23 卷, 第 1 期
页码
5
DOI
10.1186/s12944-024-02004-4
语言
ENGLISH
成果收录
SCIE
资助标注
National Key Research and Development Program of China

作者

  • C

    Chen, Hui-fen (第一作者)

    2 · guangzhou univ chinese med

  • X

    Xiao, Bing-jie

    2 · guangzhou univ chinese med

查看全部 11 位作者收起作者
  • C

    Chen, Lin-yi

    2 · guangzhou univ chinese med

  • O

    Ouyang, Wen-wei

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Z

    Zhang, Xian-long

    2 · guangdong prov hosp · guangzhou univ chinese med

  • H

    He, Zhi-ren

    2 · guangdong prov hosp · guangzhou univ chinese med

  • F

    Fu, Li-zhe

    2 · guangdong prov hosp · guangzhou univ chinese med

  • T

    Tang, Fang

    2 · guangdong prov hosp · guangzhou univ chinese med

  • T

    Tang, Xiao-na

    guangzhou univ chinese med

  • L

    Liu, Xu-sheng (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • W

    Wu, Yi-fan (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417